| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 83,014 | 80,984 | 47,110 | | Cost of Revenue | 25,671 | 26,569 | 22,214 | | | Gross Profit | 57,343 | 54,415 | 24,896 | | | Operating Expenses | | Research Development | 188 | 162 | 330 | | Selling General and Administrative | 19,015 | 23,623 | 21,485 | | Non Recurring | 6,525 | 1,588 | 2,561 | | Others | 36,552 | 34,971 | 18,320 | | | | Total Operating Expenses | 62,280 | 60,344 | 42,696 | | | | Operating Income or Loss | (4,937) | (5,929) | (17,800) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,911) | (431) | 977 | | Earnings Before Interest And Taxes | (9,848) | (6,360) | (16,823) | | Interest Expense | 27,520 | 29,327 | 9,176 | | Income Before Tax | (37,368) | (35,687) | (25,999) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,368) | (35,687) | (25,999) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (37,368) | (35,687) | (25,999) | | Preferred Stock And Other Adjustments | (50) |
-
|
-
| | | Net Income Applicable To Common Shares | ($37,418) | ($35,687) | ($25,999) |
|
0.22% Nasdaq 
0.05 (3.57%) 
Income Statement
